Genomics

Dataset Information

Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Ra antibody, is required to broadly inhibit type 2 inflammation


ABSTRACT: Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Ra antibody, is required to broadly inhibit type 2 inflammation

PROVIDER: PRJNA591357 | ENA |

REPOSITORIES: ENA